hsa-miR-383

ncRNA information

ncRNA name

hsa-miR-383

Specific or universal ncRNAs

Specific ncRNAs

Class

MicroRNA

Biomarker

No

Biomarker application

Upstream regulatory factors

Not available

Downstream target

EIF5A2

Cancer information

Cancer name

Hepatocellular Carcinoma

Cancer site

Liver

Treatment information

Treatment type

Chemotherapy

Drug

Doxorubicin

Impact of wild-type ncRNA on chemotherapy resistance

Impact of knockdown of ncRNA on chemotherapy resistance

Impact of overexpression of ncRNA on chemotherapy resistance

Down

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Not available

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

MiR-383 inhibited Dox resistance in HCC cells by targeting EIF5A2. Targeting the miR-383/EIF5A2 might help to alleviate the chemoresistance of HCC cells.

Tissue resource

human hepatocellular carcinoma cell lines Huh-7

human hepatocellular carcinoma cell lines HepG2

human hepatocellular carcinoma cell lines SUN-387

human hepatocellular carcinoma cell lines SUN-449

Experiment

RT-PCR,Western blot


Institute

the Type Culture Collection of the Chinese Academy of Sciences

Country

China

Continent

Asia